Episode 37: Clinical Conversations: Anti-Obesity Medicines Under Development

April 19, 2021 00:35:27
Episode 37: Clinical Conversations: Anti-Obesity Medicines Under Development
Obesity: A Disease
Episode 37: Clinical Conversations: Anti-Obesity Medicines Under Development

Apr 19 2021 | 00:35:27

/

Show Notes

In this episode, obesity medicine specialist and OMA Clinical Education Director, Nicholas Pennings, DO, FOMA, Dipl. ABOM interviews Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC, a highlighted speaker from Overcoming Obesity 2020 – Virtual, about new pharmaceutical agents in development to treat obesity. Topics covered include why anti-obesity medicines may be necessary in treatment, treatment targets and efficacy of newer pharmaceutical agents, role of combination medications in treatment, and a discussion about stigma and bias around anti-obesity medications.

You can access more information about Obesity Medicine podcasts and other resources from the clinical leader in Obesity Medicine at www.obesitymedicine.org/podcasts.

Episode Guests

Nicholas Pennings, DO, FOMA, Dipl. ABOM

Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC

Resources Mentioned

Anti-Obesity Medications in the Pipeline Lecture

Other Episodes

Episode 0

September 03, 2021 00:13:32
Episode Cover

Episode 46: Article Reviews: Determinants of Weight Loss Maintenance

In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC and Sarah Wells, MD discuss a recent article about...

Listen

Episode 0

April 24, 2023 00:23:22
Episode Cover

Episode 80: Clinical Conversations: The Role of Physical Activity in Weight Management

In this episode, Obesity Medicine Specialist and OMA Clinical Education Director Nicholas Pennings, DO, FOMA, FACOFP, and John Jakicic, PhD, discuss the importance of...

Listen

Episode 89

January 26, 2024 00:16:54
Episode Cover

Episode 89: Article Reviews: Prior Authorizations for Anti-Obesity Medications

In this episode, Dr. Harold Bays and Dr. Carolynn Francavilla discuss their experience with prior authorizations for obesity medications including the highly effective GLP-1...

Listen